![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Epigenomics Wins FDA Approval for Epi proColon
Epigenomics Wins FDA Approval for Epi proColon
![](https://www.fdanews.com/ext/resources/test/Device_Images4/FDA_Logo_Large.gif?t=1486528488&width=430)
The FDA has approved Epigenomics AG’s colorectal cancer screening blood test Epi proColon, the German-American diagnostics company announced Wednesday.
The test will be made available in the U.S. as part of a joint commercialization agreement with Polymedco.
The test is a noninvasive alternative for patients who would rather not undergo colonoscopies or fecal immunochemical tests. — Anisa Jibrell
Upcoming Events
-
11Jul
-
18Jul
-
21Oct